Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET/CT with Iomeron 400 in patients with suspected malignant liver lesions
2005-006053-25Phase 4Completed
- Sponsor
- Bracco Group
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of iomeprol in liver cancer, sponsored by Bracco Group. Primary endpoint: Feasibility of using Iomeprol 400 in liver PET/CT. Started Jun 2006; status: completed.
02
Drugs
iomeprol
03
Conditions
liver cancer
Beyond the preview
Go deeper on 2005-006053-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-006053-25.